These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Increased response to arachidonic acid and U-46619 and resistance to inhibitory prostaglandins in patients with chronic myeloproliferative disorders. Cortelazzo S; Galli M; Castagna D; Viero P; de Gaetano G; Barbui T Thromb Haemost; 1988 Feb; 59(1):73-6. PubMed ID: 3129810 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous study of platelets and phagocytes in myeloproliferative disorders. Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727 [TBL] [Abstract][Full Text] [Related]
10. Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Cortelazzo S; Barbui T; Bassan R; Dini E Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970 [TBL] [Abstract][Full Text] [Related]
13. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis. Mindner K; Ostermann G; Hochhaus A; Höche D; Till U Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953 [TBL] [Abstract][Full Text] [Related]
14. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin]. Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140 [TBL] [Abstract][Full Text] [Related]
15. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders. Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512 [TBL] [Abstract][Full Text] [Related]
16. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383 [TBL] [Abstract][Full Text] [Related]
17. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146 [TBL] [Abstract][Full Text] [Related]
18. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations. Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946 [TBL] [Abstract][Full Text] [Related]
19. Pathobiology of animal platelets. Meyers KM Adv Vet Sci Comp Med; 1985; 30():131-65. PubMed ID: 3004158 [No Abstract] [Full Text] [Related]
20. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder. Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]